The summer months bring a heightened awareness of tick-borne illnesses, with Lyme disease and Rocky Mountain spotted fever often taking center stage. However, there's another group of pathogens lurking in the shadows, ready to make their mark on the global health landscape. Enter the nairoviruses, a diverse family of RNA viruses carried by ticks across multiple continents, including Asia, Europe, Africa, and now, alarmingly, the western United States.
Nairoviruses pose a unique threat, causing a range of symptoms from high fevers and severe headaches to more serious organ dysfunction. One particularly concerning member of this family is the Crimean-Congo hemorrhagic fever virus (CCHFV), which has a high fatality rate and is considered a global-level threat. These viruses are transmitted by ticks that feed on a variety of hosts, including wildlife, livestock, and, of course, humans.
Recent human infections have been reported in China and Japan, with viruses like Songling virus (SGLV), Tacheng tick virus 1 (TTV1), and Yezo virus (YEZV) making their presence known. Additionally, an outbreak caused by Beiji virus (BJNV) affected over 100 patients in northeastern China. And the threat is not limited to Asia; researchers have identified the Pacific Coast Tick nairovirus (PCTNV) in the western United States, specifically in the Dermacentor occidentalis tick, which is known to transmit Rocky Mountain spotted fever.
A recent study published in ACS Infectious Diseases sheds light on how these emerging viruses manage to evade our immune defenses. All orthonairoviruses produce a specialized enzyme called ovarian tumor protease (OTU), which has the ability to remove small protein tags, namely ubiquitin and ISG15, from human proteins. These tags act as crucial alarm signals, triggering immune responses. By removing these tags, the viruses effectively disarm our immune system, allowing them to thrive.
The study focused on four emerging nairoviruses: SGLV, TTV1, YEZV, and PCTNV. Among these, PCTNV stood out for its exceptional ability to remove both ubiquitin and ISG15 tags. This suggests that PCTNV may be particularly adept at evading human immunity, a worrying prospect given its presence in a tick species that commonly bites humans along the Pacific Coast.
To gain a deeper understanding, the researchers resolved high-resolution crystal structures of several OTU proteases. These structural insights allowed them to develop computational models that can predict the potential threat posed by different nairoviruses. As the authors put it, "The biochemical and structural insights provide a path forward for predicting OTU activity among current and emerging nairoviruses."
The implications of this research are far-reaching. Predictive tools like these could be a game-changer for public health agencies, enabling them to monitor and respond to new tick-borne viruses before they become widespread. As Dr. Scott D. Pegan, the corresponding author, emphasizes, "This study reinforces the need for vigilance not only against tick bites but also against the specific types of ticks that an individual may encounter, as they may carry diseases beyond our usual radar."
In conclusion, the emergence of nairoviruses as a significant health threat underscores the importance of ongoing research and surveillance. With the right tools and knowledge, we can stay one step ahead of these stealthy pathogens, ensuring a healthier and safer future for all.
